Table 4.
Clinically Important severe complications greater than or equal to Clavien grade 3a in the neoadjuvant SBRT and neoadjuvant CRT groups.
Complication type | Neoadjuvant SBRT n = 14 (23.0% of the total of 61 patients) |
Neoadjuvant CRT n = 30 (28.0% of the total of 107 patients) |
P |
---|---|---|---|
Reoperation | 3 (5%) | 8 (8%) | .519 |
Postoperative pancreatic fistula requiring drain placement |
3 (5%) | 6 (6%) | .849 |
Clinically important bleeding event |
4 (7%) | 4 (4%) | .409 |
Sepsis with organ dysfunction requiring critical care |
3 (5%) | 8 (8%) | .519 |
Respiratory failure requiring intubation |
2 (3%) | 7 (7%) | .366 |
Other invasive procedure |
3 (5 %) | 4 (3.4%) | .713 |
Death | 1 (2%) | 3 (3%) | .634 |